Efficacy and safety of pioglitazone in type 2 diabetes in the Indian patients: Results of an observational study.

Indian J Endocrinol Metab · 2013 · PMC3743375 · PMID 23961491

Europe PMC DOI

hedged sentence

0.0001

closest p · 0.0× alpha

0.0001

boldest claim

The sentences

highly significantP < 0.0001actually significant

The difference in mean value of FBG showed a highly significant decrease ( P < 0.0001) from baseline to end of treatment, i.e., from 167.0, (59.16) 172.6 (58.51) and 171.0 (39.47) to 140.2, (26.46) 143.8 (22.04) and 138.5 (27.82) mg/dL.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.